Zobrazeno 1 - 10
of 18
pro vyhledávání: '"A. L. Chudinov"'
Autor:
A. M. Lila, I. Z. Gaydukova, O. N. Anoshenkova, I. G. Bannikova, I. B. Vinogradova, M. L. Goldman, S. Yu. Davidian, L. P. Evstigneeva, O. E. Epifanova, E. V. Zemerova, A. I. Zagrebneva, L. V. Ivanova, A. K. Karibova, I. V. Menshikova, O. N. Mironenko, M. P. Mikhailova, N. E. Nikulenkova, I. M. Patrikeeva, T. V. Plaksina, G. R. Savvina, R. R. Samigullina, L. E. Sarantseva, J. V. Usacheva, O. P. Ukhanova, G. F. Fatkhullina, A. L. Chudinov, I. A. Shafieva, S. P. Yakupova
Publikováno v:
Современная ревматология, Vol 18, Iss 3, Pp 32-43 (2024)
The efficacy and safety of levilimab (LVL) in patients with active rheumatoid arthritis (RA) has been confirmed in controlled clinical trials. This article presents the results of a preliminary analysis of a non-interventional observational study of
Externí odkaz:
https://doaj.org/article/4031788a32de403ebea6e82d4f01065d
Autor:
Sh. Erdes, V. I. Mazurov, I. Z. Gaydukova, O. N. Anoshenkova, I. B. Vinogradova, Yu. Yu. Grabovetskaya, S. Yu. Davidian, O. E. Epifanova, N. A. Kiryukhina, L. V. Masneva, I. V. Menshikova, O. N. Mironenko, N. E. Nikulenkova, T. V. Povarova, A. N. Polyatika, R. R. Samigullina, A. E. Sizikov, I. N. Totrov, I. F. Umnova, J. V. Usacheva, A. L. Chudinov
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 6, Pp 700-710 (2024)
Background. Netakimab has shown high efficacy in controlled clinical trials in the treatment of patients with ankylosing spondylitis (AS). This article presents results of an observational study of netakimab using in routine clinical practice.Methods
Externí odkaz:
https://doaj.org/article/7e5bc44473f34733b5ff6008d493e861
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 1 (2022)
The beginning of the 21st century was marked by a simultaneous changes in view on pathogenesis, diagnostics and treatment of axial spondyloarthritis (axSpA). Anti-TNFα inhibitors were the first biologics prescribed in axSpA. 20 year after the biolog
Externí odkaz:
https://doaj.org/article/e01d53f1480a48da84a49c11b15458e0
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 146-153 (2020)
The article presents the relevance of the problem of postmenopausal osteoporosis (OP) in modern medicine, due to the social and economic consequences of fractures. The pathogenetic mechanisms of its formation are highlighted, indicating that during p
Externí odkaz:
https://doaj.org/article/bb15a7d96bd042848203464de5c9cf43
Publikováno v:
Медицинский совет, Vol 0, Iss 8, Pp 102-112 (2020)
The article discusses the participation of interleukin-6 (IL6) in the formation of pathogenetic mechanisms of immuno-inflammatory diseases (IID). IL6 is one of the central cytokine in progressive IID. The biological activity of IL6 is determined by i
Externí odkaz:
https://doaj.org/article/ad47cb706b664c16a5ff4f88ea905e15
Autor:
M. Yu. Pervakova, A. L. Chudinov, S. V. Lapin, I. B. Belyaeva, V. I. Mazurov, T. V. Blinova, E. A. Surkova, V. L. Emanuel, O. V. Inamova
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 2, Pp 164-168 (2017)
α1-Antitrypsin (α1-AT) deficiency is a common genetic disorder characterized by low serum α1-AT levels and a clinical manifestation of pulmonary emphysema and liver disease. In addition to its classical manifestations, α1-AT deficiency frequently
Externí odkaz:
https://doaj.org/article/89721449a6d24e1ab71aeb3ed5f352c4
Autor:
M. Y. Pervakova, V. L. Emanuel, O. N. Titova, S. V. Lapin, V. I. Mazurov, I. B. Belyaeva, A. L. Chudinov, T. V. Blinova, E. A. Surkova
Publikováno v:
International Journal of Rheumatology, Vol 2016 (2016)
The deficiency of alpha-1 protease inhibitor, or alpha-1-antitrypsin (A1AT), predisposes to chronic lung diseases and extrapulmonary pathology. Besides classical manifestations, such as pulmonary emphysema and liver disease, alpha-1-antitrypsin defic
Externí odkaz:
https://doaj.org/article/bc217c4043464d38b6a36aeb9c61d463
Autor:
I. A. Artemev, E. I. Ermolenko, M. P. Kotyleva, N. P. Gladysheva, A. N. Tsapieva, I. Z. Gaydukova, A. L. Chudinov, A. N. Suvorov, A. L. Maslyansky
Publikováno v:
Russian Journal for Personalized Medicine. 3:80-97
Spondyloarthritis (SpA) is a group of chronic inflammatory diseases of the musculoskeletal system involving of the axial skeleton and extra-articular manifestations such as inflammatory bowel diseases. Some violations of the intestinal microbiome oft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56455d0cb2126bccf5790667d184bae9
https://doi.org/10.18705/2782-38062023-3-1-80-97
https://doi.org/10.18705/2782-38062023-3-1-80-97
Autor:
V. I. Mazurov, I. B. Belyaeva, E. A. Trofimov, I. V. Oktyabrskaya, R. R. Samigullina, А. L. Chudinov, O. V. Inamova
Publikováno v:
Medical alphabet. :28-35
Objective. To study the effect of various basic and genetic engineering biological therapies (infliximab, rituximab, tocilizumab) used as first, second- and third-line drugs in combination with methotrexate on clinical course, quality of life (QOL),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d66d8e9f30b059665284e4732c1d365
https://doi.org/10.33667/2078-5631-2022-29-28-35
https://doi.org/10.33667/2078-5631-2022-29-28-35
Publikováno v:
Medical alphabet. :30-34
The article reviews the clinical symptoms, main complications in patients with ANCA-associated systemic vasculitis (granulomatous with polyangiitis, microscopic polyangiitis, eosinophilic granulomatous with polyangiitis) and polyarteritis nodosa duri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c27bb3a208df264729ce988b3a0c8463
https://doi.org/10.33667/2078-5631-2021-33-30-34
https://doi.org/10.33667/2078-5631-2021-33-30-34